@farmerbob or anyone else (Beaza) what multiple would we command of our current shareprice if we obtain 2mg/kg twice weekly and trial metrics that only require an approx 40 mill USD (required for stage 2 of phase 3), that leaves the options open to apply for Accelerated Approval designation at the conclusion of stage 2. And acknowledgement of the mri and biomarker data pointing at a future DMOAD label. With 50 mill USD covered by the first tranche of a regional deal in April 2024
@farmerbob or anyone else (Beaza) what multiple would we command...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $91.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $36.40K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40816 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 44646 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |